查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1820174

2025-2033年人工授精市场报告，按类型（子宫内、子宫颈内、阴道内、输卵管内）、来源类型（AIH-丈夫、AID-捐赠者）、最终用途（医院和诊所、生育中心等）和地区划分

Artificial Insemination Market Report by Type (Intrauterine, Intracervical, Intravaginal, Intratubal), Source Type (AIH-Husband, AID-Donor), End Use (Hospitals and Clinics, Fertility Centers, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球人工授精市场规模达23亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到46亿美元，2025-2033年期间的复合年增长率（CAGR）为7.15%。北美是最大的地区，这得益于人们对人工授精优势的认识不断提高、人均消费者支出不断增加以及医疗保健支出不断增加。此外，不孕率上升、生活方式快速改变以及疾病盛行率不断上升也是推动市场需求的一些关键因素。

人工授精产业正面临巨大的变化，这得益于技术创新、人们行为的转变以及各行各业日益广泛的应用。资料分析在人工授精中的应用日益广泛，这是改变市场的主要趋势之一。无论是在人类生育或畜牧养殖业，资料分析都被用来提高人工授精程序的效率和准确性。在人类生育领域，诊所现在正在使用巨量资料和人工智慧 (AI) 演算法来确定最佳授精时间、增强精子和卵子的选择并最大限度地改善胚胎培养环境。透过使用这些资料，生育医生可以根据患者的独特需求提供个人化的治疗方案，从而增加成功怀孕的可能性。机器学习 (ML) 和人工智慧电脑演算法也被用于对大型资料集进行分类，这有助于进一步了解不孕症模式和改善临床结果。

人工授精市场趋势：

人工授精技术的进步

技术创新极大地推动了人工授精市场的发展，提高了人工授精的效率、成功率和可近性。在人类生育治疗领域，精子筛选、胚胎培养和冷冻保存技术的进步正在提高人工授精的准确性和有效性。基因筛检和胚胎分级等方法日益复杂，为接受人工授精生殖治疗的患者带来了更好的治疗效果。例如，阿联酋卫生和预防部 (MoHAP) 宣布，将从 2025 年 1 月初开始，在全国范围内对所有有意结婚的阿联酋公民实施强制性基因检测，并将其作为婚前筛检计画的一部分。此外，在畜牧养殖领域，精液冷冻和储存技术的进步使得优质精液的保存和利用率得到提高。农场人工授精和自动化技术进一步提高了农业人工授精过程的有效性，使农民能够减少人工授精的干预。

人工授精在畜牧养殖的应用日益广泛

人工授精在动物育种中的应用日益广泛，大大促进了市场的成长。畜牧养殖户越来越多地使用人工授精来提高畜群质量，尤其是在牛、猪和家禽方面。人工授精帮助养殖户选择性地培育出具有优良特性（例如抗病性强、产奶量高、肉质优良）的动物，从而提高生产力和盈利能力。消费者对食品品质的关注日益加深，对优质肉类和乳製品的需求也随之增长，这推动了人工授精的应用。人工授精也为改良畜群遗传和解决近亲繁殖问题提供了解决方案，尤其是在遗传多样性水平较低的牲畜。 2025年，联邦内阁批准了修订后的「国家畜牧业发展计画」（RGM），以促进畜牧业的发展。更新后的使命将作为发展计画倡议的中央部门部分执行，新增支出100亿卢比，使第十五届财政委员会（2021-22至2025-26年）期间的总资金达到340亿卢比。该计划将维持其主要职能，包括加强精液站和人工授精网络，利用性别分选精液开展公牛生产和加速品种改良项目，促进技能发展和农民教育工作，以及创建卓越中心并支持中央养牛场。

生育治疗需求不断成长

生育治疗需求的不断增长是人工授精领域（特别是在人类生殖医学领域）发展的主要驱动力之一。联合国人口基金（UNFPA）发布的《2025年世界人口状况报告》（SOWP）题为《真正的生育危机》指出，三分之一的印度成年人（36%）会遭遇意外怀孕，30%的人未能实现生育更多或更少孩子的愿望。随着社会观念的转变，大多数人和夫妇因个人或工作原因选择延后生育，导致不孕症病例增加。这种转变推动了对辅助生殖技术（ART），例如人工授精的需求。不孕症发病率的不断上升，通常与生活方式、医疗状况和环境污染物有关，这进一步刺激了生育治疗的需求。随着人们对解决生育问题的兴趣日益浓厚，人工授精越来越被证明是一种关键的解决方案，因为它具有非侵入性且成功率高。

人工授精市场成长动力：

政府政策与支持

政府透过实施各种政策和项目，主要在农业和卫生领域推广人工授精技术的应用，促进了市场成长。在农业领域，许多政府提供补贴、资金奖励和拨款，以推广人工授精在育种上的应用。这些政策使农民能够利用先进的生殖技术，而这些技术原本对他们来说太昂贵。此外，政府还在基础设施建设方面进行投资，例如为农民和兽医专家提供人工授精培训设施，以确保拥有一支熟练的劳动力队伍，从而促进人工授精的推广。在人类生育领域，政府越来越多地向生育诊所提供补贴，规范依赖人工授精的生殖技术，并为生育治疗提供经济援助或保险。

社会接受度与文化转变

社会接受度以及对计划生育和生育治疗态度的文化转变，正在推动对人工授精的需求。随着社会价值观的变化，越来越多的个人和夫妇将职业抱负、高等教育和自我提升置于首要地位，从而推迟了结婚生子的时间。这些趋势转化为人工授精等生育治疗的使用率上升，因为人们更倾向于避免晚年自然受孕。随着人们越来越多地谈论生育问题并选择基于人工授精的方法，对不孕症和辅助生殖技术的污名化也逐渐消退。这种社会态度的转变使人工授精成为一种更容易被接受的受孕方式。同样，人工授精正在改变畜牧业的面貌，成为一项主流技术，农民对其增强动物遗传、最大限度地提高效率和减少碳足迹的能力表示欢迎。

经济效益和成本效益

经济条件正成为人工授精产业发展的驱动力，尤其是在畜牧养殖领域。随着传统育种技术（例如，饲养大量公牛或进行自然交配）的成本不断上涨，人工授精正成为降低成本的解决方案。人工授精使农民能够利用领先公牛的优质基因，而无需繁重的基础设施，从而将育种成本降至最低。这种经济实惠的成本正在帮助农民，尤其是发展中国家的农民，提高其农场的获利能力和生产力。同样，在人类生育市场，与其他辅助生殖技术相比，人工授精的经济实惠使其成为大多数人的可行选择。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球人工授精市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 宫内
  • 子宫颈内
  • 阴道内
  • 输卵管内

第七章：市场区隔：依来源类型

  • AIH-丈夫
  • AID-捐助者

第 8 章：市场区隔：最终用途别

  • 医院和诊所
  • 生育中心
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Conceivex Inc.
    • FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation)
    • Genea Limited
    • Genus plc
    • Hamilton Thorne Inc.
    • Hi-Tech Solutions
    • Kitazato Corporation
    • Pride Angel
    • Rinovum Women's Health LLC
    • Rocket Medical plc
    • TenderNeeds Fertility LLC
    • Vitrolife AB
Product Code: SR112025A4023

The global artificial insemination market size reached USD 2.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.15% during 2025-2033. North America represents the largest region owing to the heightened awareness about the advantages of artificial insemination, the rising consumer per capita expenditure, and increasing healthcare expenditure. Moreover, increasing infertility rates, rapid lifestyle changes, and escalating prevalence of medical conditions represent some of the key factors driving the market demand.

The artificial insemination industry is facing tremendous changes driven by a cocktail of technological innovation, shifts in people's behavior, and increasing uses in various industries. The increasing use of data analytics in artificial insemination is one of the major trends transforming the market. Both in human fertility and in the livestock breeding industry, data analytics is being utilized to improve the efficiency and accuracy of artificial insemination procedures. In human fertility, clinics are now using big data and artificial intelligence (AI) algorithms to identify the optimal times for insemination, enhance sperm and egg selection, and maximize embryo culture environments. By using this data, fertility doctors can provide individualized treatment options tailored to the patient's unique requirements, thus increasing the possibilities of successful pregnancy. Machine learning (ML) and AI computer algorithms are also being utilized to sort through large data sets, which assist in further understanding infertility patterns and enhanced clinical outcomes.

Artificial Insemination Market Trends:

Technological Advancements in Artificial Insemination

Technological innovation is largely propelling the artificial insemination market through enhanced efficiency, success rates, and accessibility of artificial insemination procedures. In human fertility therapy, technological advancements in sperm selection, embryo culture, and cryopreservation are augmenting the accuracy and efficacy of artificial insemination. Methods like genetic screening and embryo grading are increasingly becoming sophisticated, translating to improved results for patients receiving artificial insemination-based reproductive therapies. For instance, the Ministry of Health and Prevention (MoHAP) announced that compulsory genetic testing will be implemented as part of the premarital screening program for all Emiratis intending to marry across the country, beginning in early January 2025. Moreover, in livestock breeding, the advancement of technology in semen freezing and storage is enabling improved preservation and longer utilization of quality semen. On-farm artificial insemination and automation are further enhancing the effectiveness of artificial insemination processes in agriculture to allow farmers to conduct insemination with reduced intervention.

Growing Usage of Artificial Insemination in Livestock Breeding

Growing usage of artificial insemination in animal breeding is significantly contributing to the growth of the market. Livestock farmers are increasingly using artificial insemination to enhance the quality of their herds, particularly in cattle, pigs, and poultry. Artificial insemination is helping farmers to selectively breed animals with superior characteristics like resistance to diseases, increased milk output, and quality meat, leading to enhanced productivity and profitability. This adoption is driven by increasing demand for quality meat and dairy because consumers are becoming concerned about the quality of food. Artificial insemination is also offering an answer for improving the herd genetics and handling the issue of inbreeding, especially in the livestock with low levels of genetic diversity. In 2025, the Union Cabinet sanctioned the Revised Rashtriya Gokul Mission (RGM) to enhance development in the livestock industry. The updated mission will be executed as a Central Sector part of the Development Programmes initiative, with an added expenditure of ₹1,000 crore, raising the overall funding to ₹3,400 crore for the 15th Finance Commission period from 2021-22 to 2025-26. The program will maintain its primary functions, which involve enhancing semen stations and artificial insemination networks, executing bull production and expedited breed enhancement programs with sex-sorted semen, promoting skill development and farmer education efforts, and creating Centres of Excellence while bolstering Central Cattle Breeding Farms.

Growing Fertility Treatment Demand

Growing demand for fertility treatments is one of the primary drivers of the artificial insemination sector, specifically in human reproductive medicine. The 2025 State of World Population (SOWP) Report from the United Nations Population Fund (UNFPA), named 'The Real Fertility Crisis', indicates that one in three adult Indians (36%) encounters unintended pregnancies, and 30% have unfulfilled wishes for having either more or fewer children. As societal attitudes change, most people and couples are opting to postpone childbearing because of personal or work-related issues, thus contributing to the rise in infertility cases. This transformation is driving the demand for assisted reproductive technologies (ART), such as artificial insemination. The increasing incidence of infertility, frequently associated with lifestyle factors, medical conditions, and environmental contaminants, is further stimulating the demand for fertility treatments. With increased interest in overcoming fertility issues, artificial insemination is increasingly proving to be a key solution because it is non-invasive and has high success rates.

Artificial Insemination Market Growth Drivers:

Government Policies and Support

Government assistance is contributing to the market growth by implementing various policies and programs that promote the use of artificial insemination technologies, mainly in agriculture and the health sector. In the agricultural sector, numerous governments are providing subsidies, monetary incentives, and grants to promote the use of artificial insemination in breeding. Such policies are enabling farmers to avail themselves of sophisticated reproductive technologies that would otherwise be too expensive for them. Also, governments are making investments in infrastructure to develop, for example artificial insemination artificial insemination training facilities for farmers and veterinary experts to ensure the presence of a skilled workforce to facilitate the adoption of artificial insemination. In the field of human fertility, governments are increasingly offering subsidies to fertility clinics, regulating artificial insemination-reliant reproductive technologies, and providing financial aid or insuring fertility treatments.

Social Acceptance and Cultural Shifts

Social acceptance and cultural shifts in attitudes toward family planning and fertility treatments are driving the demand for artificial insemination. With changing societal values, more people and couples are setting career aspirations, higher education, and self-improvement as top priorities, resulting in postponing marriage and having children. These trends are translating into increased use of fertility treatments, such as artificial insemination, as people are preferring to avoid natural conception later in life. The stigma regarding infertility and assisted reproductive technology is also slowly fading as people increasingly talk about their fertility issues and choose artificial insemination-based approaches. This change in the social attitudes is making artificial insemination a more accepted way to conceive. In the same way, artificial insemination is changing the face of livestock farming, becoming a mainstream technology with farmers welcoming its ability to enhance animal genetics, maximize efficiency, and minimize the carbon footprint.

Economic Benefits and Cost-Effectiveness

Economic conditions are becoming the driving force behind the artificial insemination industry, especially within livestock breeding. With the expense of traditional breeding techniques, for example, keeping extensive herds of bulls or incurring costs for natural mating, on the increase, artificial insemination is becoming a cost-cutting solution. Artificial insemination enables farmers to utilize quality genetics from leading bulls with no need for heavy infrastructure, keeping breeding expenses down to a fraction. This affordability is assisting farmers, particularly in developing countries, in enhancing the profitability and productivity of their farms. In the same way, in the market for human fertility, the affordability of artificial insemination over other assisted reproductive technologies, is making it a viable choice for most people.

Global Artificial Insemination Industry Segmentation:

Breakup by Type:

  • Intrauterine
  • Intracervical
  • Intravaginal
  • Intratubal

The intrauterine segment dominates the market

According to the artificial insemination market outlook, intrauterine insemination involves placing sperm directly into the uterus, increasing the chances of sperm reaching the egg for fertilization. IUI generally offers higher success rates, particularly when dealing with male infertility factors such as low sperm motility. This makes it a preferred option for many patients.

Breakup by Source Type:

  • AIH-Husband
  • AID-Donor

According to the artificial insemination market outlook report, AIH involves using the husband's (or male partner's) sperm for insemination, often after sperm preparation to optimize chances of fertilization. One of the primary drivers of AIH is male factor infertility, which can involve low sperm count, poor sperm motility, or abnormal sperm morphology. AIH is often used when the sperm is viable but needs to be concentrated or processed for better chances of fertilization. Moreover, AID involves using donor sperm, typically from a sperm bank, to inseminate the woman. This is often done when the male partner's sperm is not viable or in cases where the woman is single or in a same-sex relationship.

Breakup by End Use:

  • Hospitals and Clinics
  • Fertility Centers
  • Others

The fertility centers segment spearheads the market

According to the artificial insemination market forecast report, the demand for Artificial Insemination (AI) in fertility centers is driven by a combination of medical, technological, demographic, and social factors. Fertility centers play a critical role in providing specialized reproductive services, and they are at the forefront of delivering assisted reproductive technologies (ART) such as intrauterine insemination (IUI), intracervical insemination (ICI), and other AI procedures.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America dominates the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America dominates the market.

According to the artificial insemination market statistics, some of the factors accelerating the North America artificial insemination market include the surging awareness regarding the advantages of artificial insemination, the rising consumer per capita expenditure, and burgeoning healthcare expenditure. The rising infertility rates among both men and women, driven by lifestyle changes, stress, pollution, delayed childbearing, and certain medical conditions, are a major driver of the AI market. Infertility rates have steadily increased in the region, with many couples and individuals turning to artificial insemination as a solution. Moreover, in North America, many women are choosing to delay parenthood due to career, financial, or personal reasons. For instance, according to an article published by Forbes, over the last decade, as more women of all social groups have emphasized education and profession, deferring motherhood has become practically universal among American women. As maternal age increases, fertility declines, leading to more individuals seeking assisted reproductive technologies (ART), including artificial insemination, to conceive. According to the artificial insemination market research, this is augmenting the regional market.

Competitive Landscape:

The artificial insemination market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

  • Conceivex Inc.
  • FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation)
  • Genea Limited
  • Genus plc
  • Hamilton Thorne Inc.
  • Hi-Tech Solutions
  • Kitazato Corporation
  • Pride Angel
  • Rinovum Women's Health LLC
  • Rocket Medical plc
  • TenderNeeds Fertility LLC
  • Vitrolife AB

Key Questions Answered in This Report

  • 1.How big is the global artificial insemination market?
  • 2.What is the expected growth rate of the global artificial insemination market during 2025-2033?
  • 3.What are the key factors driving the global artificial insemination market?
  • 4.What has been the impact of COVID-19 on the global artificial insemination market?
  • 5.What is the breakup of the global artificial insemination market based on the type?
  • 6.What is the breakup of the global artificial insemination market based on the end use?
  • 7.What are the key regions in the global artificial insemination market?
  • 8.Who are the key players/companies in the global artificial insemination market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Insemination Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Intrauterine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intracervical
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Intravaginal
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Intratubal
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Source Type

  • 7.1 AIH-Husband
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 AID-Donor
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Fertility Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Conceivex Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Genea Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Genus plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Hamilton Thorne Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Hi-Tech Solutions
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Kitazato Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pride Angel
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Rinovum Women's Health LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Rocket Medical plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 TenderNeeds Fertility LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Vitrolife AB
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials

List of Figures

  • Figure 1: Global: Artificial Insemination Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Insemination Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Artificial Insemination Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Artificial Insemination Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Artificial Insemination Market: Breakup by Source Type (in %), 2024
  • Figure 6: Global: Artificial Insemination Market: Breakup by End Use (in %), 2024
  • Figure 7: Global: Artificial Insemination Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Artificial Insemination (Intrauterine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Artificial Insemination (Intrauterine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Artificial Insemination (Intracervical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Artificial Insemination (Intracervical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Artificial Insemination (Intravaginal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Artificial Insemination (Intravaginal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Artificial Insemination (Intratubal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Artificial Insemination (Intratubal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Artificial Insemination (AIH-Husband) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Artificial Insemination (AIH-Husband) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Artificial Insemination (AID-Donor) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Artificial Insemination (AID-Donor) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Artificial Insemination (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Artificial Insemination (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Artificial Insemination (Fertility Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Artificial Insemination (Fertility Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Artificial Insemination (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Artificial Insemination (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Artificial Insemination Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Artificial Insemination Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Artificial Insemination Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Artificial Insemination Industry: SWOT Analysis
  • Figure 76: Global: Artificial Insemination Industry: Value Chain Analysis
  • Figure 77: Global: Artificial Insemination Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Insemination Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Artificial Insemination Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Artificial Insemination Market Forecast: Breakup by Source Type (in Million USD), 2025-2033
  • Table 4: Global: Artificial Insemination Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 5: Global: Artificial Insemination Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Artificial Insemination Market: Competitive Structure
  • Table 7: Global: Artificial Insemination Market: Key Players